Phylogenetic Analysis of Metastases Using SSNV Classification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to provide detailed insights into tumor dissemination and phylogeny, especially in cases of multiple metastases, as they are not applicable to omics data from tumors and their metastases at different sites or time points, limiting the understanding of genetic origin and differentiation of sub-populations in metastases.

Innovation Solution

The system and method analyze omics data from tumors and metastases to determine phylogeny by classifying somatic single nucleotide variants (SSNVs) as fully shared, partially shared, private, or absent, and calculating a phylogenetic profile for the primary tumor and its metastases using an error probability model and filtering criteria.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of information

If current methods are used to analyze tumor data, then general tumor clonality can be determined, but detailed insights into tumor dissemination and phylogeny of multiple metastases cannot be obtained

Engineering Contradiction:
Improvedetailed insight into tumor dissemination and phylogenyVSAvoidapplicability to omics data from tumors and metastases at different sites or time points
Core Design Contradiction:
Loss of informationVSAdaptability or versatility

Solution Approach 1:

The method segments the analysis by classifying SSNVs into distinct categories (fully shared, partially shared, private, absent) based on their presence across different tumor samples. This segmentation allows detailed phylogenetic reconstruction by tracking which variants are inherited from the primary tumor versus which arise de novo in metastases, thereby resolving the technical contradiction between obtaining detailed phylogenetic information and maintaining applicability across diverse sample types.

Inventive Principle:
Principle #1Segmentation

2Loss of information

If phylogenetic analysis of multiple metastases is performed, then understanding of metastatic heterogeneity improves, but complexity of data analysis increases

Engineering Contradiction:
Improveunderstanding of metastatic heterogeneityVSAvoidcomplexity of computational analysis
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The method applies local quality by using filtering criteria tailored to specific variant types and sample characteristics. Different filtering thresholds and parameters are applied based on the local data quality, variant frequency, and sample type, allowing complex phylogenetic analysis while managing computational complexity through adaptive, context-specific filtering strategies.

Inventive Principle:
Principle #3Local quality

3Measurement precision

If stringent filtering criteria are applied to determine SSNVs, then accuracy of phylogenetic profiling increases, but quantity of identified variants decreases

Engineering Contradiction:
Improveaccuracy of SSNV determinationVSAvoidnumber of identified SSNVs
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The method employs parameter changes by adjusting filtering thresholds and confidence levels based on the specific analysis context, sample quality, and variant frequency. This allows the system to optimize between accuracy and quantity of identified variants dynamically, applying stricter filters when high precision is critical and more permissive filters when broader variant detection is needed, thereby resolving the contradiction between measurement precision and quantity of identified variants.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20240153650A1Systems And Methods For Genetic Analysis Of Metastases
Publication Date: 2024.05.09 NANTOMICS LLC
  • US20240153650A1 patent drawing
  • US20240153650A1 patent drawing
  • US20240153650A1 patent drawing

AI summary

Contemplated systems and methods use identification and classification of somatic single nucleotide variants found in a primary tumor and metastases to determine phylogeny of the metastases.